Skip to Main Content

Will the Addyi female sexual dysfunction pill ever generate any excitement?

Two years after betting $1 billion on the drug, Valeant Pharmaceuticals (VRX) has agreed to sell Sprout Pharmaceuticals, which initially won regulatory approval for the drug, back to its shareholders. The deal ends a lawsuit filed against the drug maker by former Sprout shareholders  – and Valeant is providing a $25 million loan.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • Wrong advocacy group. Remember Hall and Oates “She’s a Maneater”. The NOW is a starchy postmenopsusal post womens libbers group that cares more about abortion rights than orgasms.

  • Hmmm – “and interactions with other medicines.” and if memory serves, that would include the ‘medicinal/ social effects of alcohol. This pill was indeed a solution that did seem to be somewhat … lacking.

Comments are closed.